Current Edition

The Incomparable Benefits of Assured Quality in Comparator Trials

The industry’s use of comparator trials is growing. Drug companies must focus on quality if they are to reap the benefits – and reduce the risks – of comparator clinical studies. The pharmaceutical industry’s expectation for comparative effectiveness research continues to increase as international governments battle to contain rising healthcare costs – with payers, physicians and patients increasingly seeking evidence of how treatments compare in safety, efficacy and also value. Dr Bashir Parkar of BAP Pharma evaluates the changing model for pharmaceutical R&D and the regulatory environment that governs it.
Logistics 2 – Comparative